Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-30
2008-10-21
Helms, Larry R. (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S375000
Reexamination Certificate
active
07439223
ABSTRACT:
The Rev peptide that binds to nucleophosmin/B23 with the highest affinity exhibits the greatest cytotoxicity on Ras-3T3 cells and inhibits tumor growth most effectively in nude mice. The efficiency of colony formation in soft agar of Ras-3T3 cells is significantly inhibited by treatment with Rev peptide. In addition, Rev peptide can potentiate the doxorubicin-induced decrease of cellular viability in U1 bladder cancer cells and inhibition of tumor growth in nude mice. Treatment of Rev peptide increases protein expression and transcriptional activity of p53 and inhibits the nucleophosmin/B23-mediated PCNA promoter activation. Peptides having high affinity of binding to molecular targets such as nucleophosmin/B23 represent a useful approach to anti-cancer biotherapeutics.
REFERENCES:
Korgaonkar et al. (Molecular and Cellular Biology, vol. 25, No. 4, pp. 1258-1271, Feb. 2005).
Janssen et al. (International Journal of Pharmaceutics, vol. 254, pp. 55-58, 2003).
Hui Jia Chan, et al., Nucleophosmin/B23-binding Peptide Inhibits Tumor Growth and Up-Regulates Transcriptional Activity of p53; Science Direct, Apr. 25, 2005.
Chang Gung University
Helms Larry R.
Natarajan Meera
Rosenberg , Klein & Lee
LandOfFree
Nucleophosmin/B23-binding peptide to inhibit tumor growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleophosmin/B23-binding peptide to inhibit tumor growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleophosmin/B23-binding peptide to inhibit tumor growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3992184